|
Early View Articles
Value in Health offers readers the opportunity to access complete articles to be published in upcoming issues of Value in Health. These articles are citable by DOI, and by volume and issue.
Early View Articles can be found at: http://www3.interscience.wiley.com/journal/120174665/issue (click "Early View" next to the issue navigation toolbar) and are scheduled to appear in the following upcoming issues of Value in Health. The final Table of Contents for each issue will be available when the final issue appears online.
Future Issues:
Value in Health June 2010 Volume 13 Issue 4
EDITORIAL / Point-Counterpoint / Letter to the Editor
Response to: A Methodology for Successfully Producing Global Translations of Patient Reported Outcomes Measures for use in Multiple Countires by Two et al Tamzin Furtado
ECONOMIC EVALUATION
Factors influencing cost-related nonadherence to medication in older adults: A conceptually based approach Kara Zivin, PhD; Scott Ratliff, MS; Michele M. Heisler, MD; Kenneth M. Langa, MD, PhD; John D. Piette, PhD
An Evaluation of the Cost-Effectiveness of Rituximab in Combination With Chemotherapy for the First-Line treatment of Follicular Non Hodgkin’s Lymphoma in the UK Joshua A. Ray, MSc, Emma Carr, PhD, G Lewis, MSc, Robert Marcus, MD
Modeling complex treatment strategies: construction and validation of a discrete event simulation model for glaucoma. Aukje van Gestel, MSc.; Johan L. Severens, Professor, PhD; Carroll A. B. Webers, MD, PhD; Henny J. M. Beckers, MD, PhD; Nomdo M. Jansonius, MD, PhD; Jan S. A. G. Schouten, MD, PhD
Social time preference for health and money elicited with a choice experiment Willem Jan Meerding, PhD, Gouke J. Bonsel, MD PhD, Werner B.F. Brouwer, PhD, Marja C. Stuifbergen, PhD, Marie-Louise Essink-Bot, MD PhD
Transferability of model-based economic evaluations: the case of trastuzumab for the adjuvant treatment of HER2-positive early breast cancer in the Netherlands B.A.B. Essers PhD, S. Seferina MhSc, V.C.G. Tjan-Heijnen MD PhD J.L. Severens PhD, A. Novák PhD, M. Pompen PhD, U. Oron MHsc, M.A. Joore PhD
Economic implications of 21-gene breast cancer risk assay from the perspective of an Israeli managed healthcare organization
Shmuel H Klang, Ph.D., Ariel Hammerman, Ph.D., Nicky Liebermann, M.D., Noa Efrat, M.D., Julie Doberne, John Hornberger, M.D., M.S.
The effect size in uncertainty analysis
Jan J Barendregt, MA PhD
DECISION-MAKER COMMENTARY
Distributions of parameters for uncertainty analysis can not be defined without using prior information Hendriek C. Boshuizen
Cost-effectiveness of osteoporosis screening followed by treatment: the impact of medication adherence
Mickaël Hiligsmann MPH, MSc, Henry-Jean Gathon PhD, Olivier Bruyère PhD, Olivier Ethgen PhD, Véronique Rabenda MPH and Jean-Yves Reginster MD, PhD
IMPACT OF WAIST CIRCUMFERENCE DIFFERENCE ON HEALTH CARE COST AMONG OVERWEIGHT AND OBESE SUBJECTS: THE PROCEED COHORT
Karen Pendergast, MPH, Anne Wolf, MS, Beth Sherrill, MStat, Xiaolei Zhou, MS, Louis J. Aronne, MD, Ian Caterson, MD, PhD, FRACP, Nicholas Finer, FRCP, Hans Hauner, MD, James Hill, PhD, Luc Van Gaal, MD, PhD, Florence Coste, MS, Jean-Pierre Despres, PhD
OUTCOMES ASSESSMENT
Using an incremental net-benefit framework for quantitative benefit-risk analysis in regulatory decision making – a case study of alosetron in irritable bowel syndrome
Larry D. Lynd, PhD, Mehdi Najafzadeh, MSc, Lindsey Colley, MSc, Michael F. Byrne, MD, Andrew R Willan, PhD, Mark A. Sculpher, PhD, F. Reed Johnson, PhD, A. Brett Hauber, PhD
Quantifying Women’s Stated Benefit-risk Tradeoff Preferences for IBS Treatment Outcomes
F. Reed Johnson, PhD, A. Brett Hauber, PhD, Semra Özdemir, MS, Larry Lynd, PhD
Effects of Method of Translation of Patient-Reported Health Outcome Questionnaires: A Randomized Study of the Translation of the Rheumatoid Arthritis Quality of Life (RAQoL) instrument for Sweden
Peter Hagell PhD, Per-Johan Hedin MD, David M Meads MSc, Lennart Nyberg PhD, Stephen P McKenna PhD
Bayesian analysis of nosocomial infection risk and length of stay in a Department of General and Digestive Surgery
Saez-Castillo, A. J., PhD, Olmo-Jimenez, M. J., PhD, Perez-Sanchez, J. M., PhD2, Negrin-Hernandez, M. A., PhD, Arcos-Navarro, A.,Dr., Diaz-Oller, J., Dr.
The suitability of Polycystic Ovary Syndrome-specific questionnaires for measuring the impact of PCOS on quality of life in clinical trials
Aysha Malik-Aslam MSc, Matthew D Reaney MSc, Jane Speight MSc PhD CPsychol
Patient Expectations and Health-Related Quality of Life Outcomes Following Total Joint Replacement
M Gonzalez Saenz de Tejada, A Escobar, C Herrera, L García, F Aizpuru, C. Sarasqueta
Assessing outcomes in liver disease patients: reliability and validity of the Spanish version of the Liver Disease Quality of Life questionnaire (LDQOL 1.0)
Teresa Casanovas MD, PhD, Laia Jané BSc, Michael Herdman MSc, Alfonso Casado PhD, Beatriz Garcia BSc, Bibiana Prat BSc, Joan Fabregat MD
International development of the Unidimensional Fatigue Impact Scale (U-FIS) Lynda C Doward MRes, David M Meads MSc, John Fisk PhD, James Twiss BSc, Peter Hagell PhD, Nadia C Oprandi PhD, François Grand’Maison MD, Virender Bhan MD, Txomin Arbizu MD, Thomas Kohlmann PhD, David Brassat MD, Benjamin J Eckert MS, Stephen P McKenna PhD
DIMENSIONALITY AND SUMMARY MEASURES OF THE SF-36 v1.6: COMPARISON OF SCALE- AND ITEM-BASED APPROACH ACROSS ECRHS II ADULTS POPULATION Mario Grassi, and Andrea Nucera on behalf of the European Community Respiratory Health Study Quality of Life Working Group
Treatment Patterns and Adherence Among Patients With Chronic Hepatitis C Virus in a United States Managed Care Population Debanjali Mitra, MA; Keith L. Davis, MA; Cynthia Beam, PhD; Jasmina Medjedovic, MSc; Vinod Rustgi, MD
ANALYSIS OF HEALTH UTILITY DATA WHEN SOME SUBJECTS ATTAIN THE UPPER BOUND OF 1: ARE TOBIT AND CLAD MODELS APPROPRIATE? Eleanor M Pullenayegum PhD, Jean-Eric Tarride PhD, Feng Xie PhD, Ron Goeree MA, Hertzel C Gerstein MD, Daria O'Reilly PhD
Word Count: 6065
Application of the disease-specific Quality of Life Assessment of Growth Hormone Deficiency in Adults (QoL-AGHDA) questionnaire in a general population: results from a French panel study Hélène Gilet, Anne Chachuat, Muriel Viala-Danten, Sébastien Auzière, Maria Koltowska-Häggström
ECONOMIC EVALUATION
Tutorial in medical decision modelling Incorporating waiting lines and queues using discrete event simulation Beate Jahn, Phd, Prof. Dr. Engelbert Theurl, Prof. Dr. Uwe Siebert, MPH, MSc, Prof. Dr. Karl-Peter Pfeiffer
CORRESPONDANCE
Response to: A Methodology for Successfully Producing Global Translations of Patient Reported Outcomes Measures for use in Multiple Countires by Two et al
Tamzin Furtado
Response to letter from Ms Tamzin Furtado
Rebecca Two
Value in Health Main
Page
|
